This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Knowing what to look for when reviewing a financial plan is essential. Discover the key factors that can impact your financial success.
23,508 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Under Armour reported a wider loss as costs climbed and revenue slipped, triggering a sharp drop in its stock. Trader...
Figma stock shows signs of a potential rebound as profitability improves and AI-driven features gain traction, even a...
A security firm reports that researchers used Claude Mythos AI to help build a macOS kernel exploit. The incident spo...
A veteran lender outlines the three biggest traps in reverse mortgages as market conditions shift and seniors hold si...
A wave of healthcare AI players trading under $50 is drawing attention for real progress in partnerships and revenue....
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...
A November-like standoff erupts as MRED suspends Zillow’s access to Chicagoland listing data, potentially reshaping h...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...
Zero Network, a gasless Ethereum Layer 2 project, is closing its standalone chain after about 18 months of operation....
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
A sharp bond selloff has investors seeking guidance on where invest bonds right. This report outlines a practical app...